FIRST-LINE TREATMENT OF PRIMARY METASTATIC HR+ HER2- BREAST CANCER [1]
FIRST-LINE TREATMENT OF PRIMARY METASTATIC HR+ HER2- BREAST CANCER
Kaja Cankar, dr. med., specializantka internistične onkologije
Doc. Dr. Erika Matos, dr. med., specialistka interne medicine in internistične onkologije